NephroGenex, Inc.
DelistedCIK 1338095fmd_1D6M03KCJ6ZSH237ZBX1Q7C0E1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2005 to Dec 31, 2015, 20 periods
Latest annual · FY2015
Millions- Operating income
- (22)
- Net income
- (23)
- Free cash flow
- (20)
Latest quarter · Q4 FY2015
Millions- Operating income
- (6)
- Net income
- (6)
- Free cash flow
- (4)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2010 to FY2015
- n/m
NephroGenex, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Operating income | -$22.3 million | -$16.6 million | 10-K 2016-03-29 · proof | |
| Net income | -$22.9 million | -$16.8 million | 10-K 2016-03-29 · proof | |
| Cash from operating activities | -$19.6 million | -$13.6 million | 10-K 2016-03-29 · proof | |
| Free cash flow | -$19.7 million | -$13.7 million | 10-K 2016-03-29 · proof | |
| Total assets | $23 million | $29.2 million | -21.2% | 10-K 2016-03-29 · proof |
| Total liabilities | $11.9 million | $9.9 million | +20.2% | 10-K 2016-03-29 · proof |
| Cash and cash equivalents | $18.8 million | $14 million | +34.7% | 10-K 2016-03-29 · proof |
- What was NephroGenex, Inc.'s operating income in fiscal 2015?
- NephroGenex, Inc. reported operating income of -$22.3 million for fiscal 2015 (the year ended Dec 31, 2015), against -$16.6 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2016. SEC
- What was NephroGenex, Inc.'s net income in fiscal 2015?
- NephroGenex, Inc. reported net income of -$22.9 million for fiscal 2015 (the year ended Dec 31, 2015), against -$16.8 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2016. SEC
- What was NephroGenex, Inc.'s cash from operating activities in fiscal 2015?
- NephroGenex, Inc. reported cash from operating activities of -$19.6 million for fiscal 2015 (the year ended Dec 31, 2015), against -$13.6 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2016. SEC
- What was NephroGenex, Inc.'s free cash flow in fiscal 2015?
- NephroGenex, Inc. reported free cash flow of -$19.7 million for fiscal 2015 (the year ended Dec 31, 2015), against -$13.7 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2016. SEC
- What are NephroGenex, Inc.'s total assets?
- As of Dec 31, 2015, NephroGenex, Inc. reported total assets of $23 million, against $29.2 million a year earlier (-21.2%). Source: the 10-K filed with the SEC on Mar 29, 2016. SEC
- What are NephroGenex, Inc.'s total liabilities?
- As of Dec 31, 2015, NephroGenex, Inc. reported total liabilities of $11.9 million, against $9.9 million a year earlier (+20.2%). Source: the 10-K filed with the SEC on Mar 29, 2016. SEC
- What are NephroGenex, Inc.'s cash and cash equivalents?
- As of Dec 31, 2015, NephroGenex, Inc. reported cash and cash equivalents of $18.8 million, against $14 million a year earlier (+34.7%). Source: the 10-K filed with the SEC on Mar 29, 2016. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1338095&period_type=annual&limit=5"Information only, not investment advice.